Skip to main content
. Author manuscript; available in PMC: 2022 Mar 7.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):208–212. doi: 10.1097/QAI.0000000000002534

Table 2.

Rates of Type 1 and Type 2 myocardial infarctions per 1000 person-years of follow-up among people living with HIV at six CNICS sites across the United States

Age category Rate (CI) Type I MI Rate (CI) Type 2 MI IRR (CI)Type 2 vs Type 1 MI, p-value
<30 0.13 (0.03–1.32) 1.31 (0.86–2.11) 10.0 (2.43–88.24), 0.001
30–39 0.71 (0.50–1.03) 1.11 (0.84–1.49) 1.57 (0.97–2.57), 0.05
40–49 2.33 (1.99–2.74) 2.06 (1.74–2.45) 0.88 (0.69–1.12), 0.3
50–59 3.91 (3.40–4.53) 3.04 (2.59–3.59) 0.78 (0.62–0.97), 0.02
60–69 5.13 (4.07–6.56) 3.42 (2.58–4.63) 0.67 (0.45–0.98), 0.03
≥70 9.32 (6.16–14.78) 8.88 (5.80–14.26) 0.95 (0.49–1.85), 0.9

CI: confidence interval; MI: myocardial infarction; IRR: incidence rate ratio